Skip to main navigationSkip to main content
The University of Southampton
Computationally Intensive Imaging

Professor Richard Oreffo DPhil DSc (Oxon) CBiol FRSB

Professor of Musculoskeletal Science, Director; Centre for Human Development, Stem Cells and Regeneration

Professor Richard Oreffo's photo

Richard Oreffo holds the chair of Musculoskeletal Science and is co-founder and Director of the Centre for Human Development, Stem Cells and Regeneration. He has held positions in USA, AstraZeneca, and University of Oxford before being appointed to a lectureship in 1999 at the University of Southampton. Richard is internationally recognised for his work on skeletal biology and the mechanisms involved in skeletal stem cell differentiation and bone regeneration. Richard has successfully trained over 41 PhD and MD students since 2002 and as of 2018-19, directly supervises/co-supervises 11 MD/PhD Graduate Fellows. 

I am particularly interested in the application of bone stem cells and regenerative medicine strategies for the repair and regeneration of damaged skeletal tissue. We have the potential to make a difference through collaborative teams here at the University of Southampton to treat devastating bone conditions.

Richard has published over 285 peer-reviewed full papers (H-index 62; >13,750 citations ISI WoS (Oct 2018)), including breakthrough publications on skeletal stem cells and nanotopography, bone regeneration as well as epigenetics in Osteoarthritis, in Nature Materials, ACS Nano, Stem Cells, Small, Arthritis and Rheumatism; holds 6 patents and is co-editor of “Epigenetic aspects of Chronic Diseases” Highly Commended in 2012 BMA Medical Book Awards.

Richard serves / has served on a number of Research Council Committees, Industrial committees and international advisory boards and holds a number of visiting professorships. He is a Fellow of the Royal Society of Biology and in 2015 was awarded a DSc by the University of Oxford.  In 2017, he founded and is CSO of Renovos Biologics Limited, a spin-out from the University of Southampton – details on Renovos Biologics Limited.


B.Sc. Honours, Biology, University of Liverpool, 1983

D.Phil. Vitamin A and Bone, University of Oxford, 1986

D.Sc  Skeletal Tissue Engineering, University of Oxford, 2015

Appointments held

Demonstrator, Oxford Brookes University, Oxford. 1985-1986

Research Fellow, Department of Medicine, Division of Endocrinology,

University of Texas, San Antonio, Texas, USA. 1987-1989

Postdoctoral Research Fellow, Zeneca Pharmaceuticals, Cheshire, UK.1990-1991

Principal Research Scientist, Zeneca Pharmaceuticals, Cheshire, UK.1991-1993

MRC Research Fellow, University of Oxford, Oxford, UK. 1993-1999

Non-Clinical lecturer, University of Southampton, Southampton, UK.1999-2002

Senior lecturer, University of Southampton, Southampton, UK.2002-2004

Reader, University of Southampton, Southampton, UK. 2004

Personal Chair in Musculoskeletal Science. 2004-present

Director of Enterprise – Faculty of Medicine, Health and Life Sciences. 2005- 2013

Associate Dean (Innovation and Enterprise), Faculty of Medicine, Health and Life Sciences. 2008-2010

Associate Dean Enterprise, Faculty of Medicine. 2010-2011

Associate Dean, International and Enterprise, 2011 - 2013

Adjunct Professor, King Saud University, Saudi Arabia. 2010-present

Research interests

The aim of the group is to understand the mechanisms of bone development, growth and regeneration, how these differ in skeletal abnormalities and diseases such as osteoporosis and osteoarthritis, and to what extent bone growth is programmed during fetal life.

Thus research in Professor Oreffo’s group is primarily centered on harnessing the potential of skeletal stem cells (whether derived from embryonic or fetal and adult sources) for the development of unique tissue engineering approaches for new cartilage and bone formation for orthopedic application. In parallel we are interested in the role of fetal programming as a consequence of maternal nutritional challenges on bone cell differentiation, activity, potential and bone function with age.

Skeletal Research - the potential of skeletal stem cells

The requirement for new bone to replace or restore the function of traumatised or degenerated bone, or for the replacement of lost mineralised tissue as a consequence of increasing age is a major clinical and socio-economic need. To date, bone formation stimulation regimes, although attractive, have yet to demonstrate clinical efficacy.

Research of the group has primarily centred on:

Understanding human skeletal stem cell biology and the development of unique tissue engineering approaches for cartilage and bone formation for orthopaedic application using human skeletal populations and, elucidating the role of fetal programming as a consequence of maternal nutritional challenge on mesenchymal progenitor cell differentiation, activity, potential and bone function with age.

This involves drawing together the elements of i) progenitor cell differentiation (specifically the control of mesenchymal stem/progenitor cell differentiation and plasticity), ii) generation of osteoconductive and inductive smart scaffold/materials (including the use of natural biomimetic environments and self -assembling scaffolds with appropriate extracellular matrix cues) and, iii) cell signal/growth factor biology to examine tissue regeneration.

Other areas of active research interest within the group include differentiation of pluripotent stem cells along the mesenchymal lineage as well as angiogenesis / revascularisation in tissue development.

The group is currently developing translational strategies for clinical application to couple cell technologies with biomimetic scaffolds in close collaboration with groups in the UK as well as international collaborations in Germany, Canada and the USA.

Thus current concepts, approaches and challenges from work in the group include:

i) The use of isolated and selected human osteoprogenitor cell populations with selected osteotropic agents in an attempt to modulate the phenotype of the skeletal stem cell to generate mineralised bone tissue,
ii) The role of epigenetics, maternal nutrition and intrauterine programming in skeletal development of related offspring
iii) Manipulation of the developmental potential of bone stem cells on modified biomimetic structures with select growth factors,
iv) Epidemiological Studies in Bone & Joint Research
v) Modelling of skeletal tissue formation – including gene network analysis as well as tissue growth modelling.
vi) Translation from bench to clinic

Although clinical efficacy has yet to be achieved, development of protocols, new tools and above all multidisciplinary approaches for de novo bone formation that utilise skeletal stem cells offer significant rewards for an increasing aged population both in terms of healthcare costs and, more importantly, improved quality of life.

Intrauterine Programming, Epigenetics, Skeletal Development and Bone Diseases

In collaboration with Prof. Cyrus Cooper (MRC Environmental Epidemiology Unit) members of HDH and a number of international collaborators we are investigating, using a variety of animal models, how maternal protein deficiency affects bone growth. Our current ex vivo analysis of bone populations shows an important role of maternal nutrition in subsequent fetal bone development with significant implications in understanding the subsequent development of bone chronic diseases in later life such as osteoarthritis.

Growth, analysis and characterization (a-g)
Skeletal stem cells
Growth of skeletal stem cells (a) and their expression of a marker enzyme
Making Bone
Growing on allograft bone for clinical application
Skeletal Stem Cells
Slice of trabecular bone captured using Computer Tomography
Bone Development

Research group

Human Development and Health

Affiliate research group

Human Development and Physiology

Research project(s)

Application of ultrasound standing wave fields for augmentation of cartilage bioengineering strategies

Targeting stem cells with nanoparticles

Promoting tissue regeneration by carrying drugs and molecules directly to stem cells.

The effects of substrate mechanics on keratinocytes and epidermal stem cell behaviour at wound sites

How does the stiffness of a wound affect how it heals?

The healing of a skin wound is a highly co-ordinated series of events involving both biochemical and biomechanical signalling. We are trying to understanding how the mechanical properties of a healing wound affects how it heals.

Postgraduate Supervision (higher research degrees)

2002 Rahul Tare PhD
2002 Xuebin Yang PhD
2003 Daniel Howard PhD
2006 Michael O’Connell PhD
2006 Sayed-Hadi Mirmalek-Sani PhD
2006 Jodie Pound PhD
2007 Jon Dawson PhD
2008 Simon Tiley MD
2008 Ben Bolland MD
2009 Ahmed El Serafi PhD
2010 Catherine Forristal PhD
2010 Ayshe Ismail PhD
2011 Peter Mitchell PhD
2011 Alex Aarvold MD
2012 Andrew Jones MD
2012 James Smith MD
2014 Edward Tayton MD
2014 Stephanie Meakins PhD
2014 Siwei Li PhD


17 PhD and MD Students


Kelvin Cheung (Yr 3)
Marco Peca (Yr 3)
Yu Hin Man (Yr 3) co-supervisor
Emma McMorrow (Yr3)
Patrick Stumpf (Yr 3) co-supervisor
Joanna Greenhough (Yr3) co-supervisor
Tsiloon Li (Yr3) co-supervisor
Ines Moreno (Yr 1)
Eduardo Scarpa (Yr 1) co-supervisor
Daniel Page (Yr 1) co-supervisor
Umesh Jonnalagadda (yr 1) co-supervisor
Emma Budd (Yr 2)
Cameron Black (Yr 2)
Agnieszka Janeczek (Yr 2) co-supervisor


Emma William
Nicholas Evans

University of Southampton

Southampton Asset Management (to 2013)
Various University Enterprise/Research Groups

National and International responsibilities

Editorial Board Biomaterials
Editorial Board Tissue Engineering
Editorial Board European Cells and Materials
Editorial Board Regenerative Medicine
Editorial Board J. Tissue Engineering
Editorial Board J, Tissue Engineering and Regenerative Medicine
Fellow Institute of Biology
Research Council for Health of the Academy of Finland (to 2013)
Member of BBSRC Healthy Organism Panel (Deputy Chair) (2007 - 2012)
ARC Research Committee (2006 - 2010)
UK National Stem Cell Network Committee (2009 - 2012)
Adjunct Professor King Saud University (2009 - present)


Serve and have served as a consultant to various SME and Pharma Companies in the area of musculoskeletal science and Bone Regeneration

Sort via:TypeorYear


Book Chapters



  • Oreffo, R., Dawson, J., Evans, N., & Ramnarine Sanchez, R. S. (2020). Structured gels IPC No. A61L 27/ 54 2006.01,A61K 47/02 2006.01,A61L 27/52 2006.01. Structured gels (Patent No. WO2020058724.) World Intellectual Property Office - WIPO.


BM5 Year 4. Delivery of on-going lectures to groups of undergraduate students studying Orthopaedics and Rheumatology. Specific lectures given on metabolic bone disease and basic bone biology.

BM5 Year 1. Provides tutorial and lectures on calcium metabolism and physiology of bone

BM4 Year 1. Provides tutorial to year 1 BM4 students on Bone Physiology.

Integrated Stem Cell PhD Programme – Stem Cell PhD Course Director and  Lead - Also teach and run projects within the programme

Professor Richard Oreffo
Faculty of Medicine University of Southampton Institute of Developmental Sciences Building Mailpoint 887 Southampton General Hospital Tremona Road Southampton SO16 6YD Tel: +44 (0)23 8120 8502

Room Number: SGH/IDS/MP887

Share this profile Share this on Facebook Share this on Twitter Share this on Weibo
Privacy Settings